We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations
Read MoreHide Full Article
Key Takeaways
GEHC's CareIntellect for Operations forecasts hospital capacity constraints up to 72 hours ahead.
The tool uses proprietary AI models, EMR data and operational inputs to recommend workflow actions.
Queen's Health Systems and Duke Health will be the first health systems to implement the application.
GE HealthCare Technologies Inc. (GEHC - Free Report) recently introduced CareIntellect for Operations, an AI-powered Software-as-a-Service (SaaS) application that enables health systems to anticipate capacity challenges up to 72 hours ahead and proactively manage emerging operational bottlenecks. The Queen’s Health Systems and Duke Health will be the first health systems to implement the application.
CareIntellect for Operations is part of GE HealthCare’s CareIntellect family of clinical and operational applications, which use a common cloud-first infrastructure. The application runs on Amazon Web Services (AWS) and is available directly from GE HealthCare and through the AWS Marketplace.
Per GE HealthCare management, CareIntellect for Operations is designed to help health systems identify where operational pressure is building and determine the appropriate next steps. The solution combines patient and operational data with proprietary AI models to provide predictive insights and workflow-connected recommendations, supporting efforts to optimize resources and manage capacity at critical decision points.
GEHC Stock Trend Following the News
Following the announcement, GEHC stock lost 0.3% at yesterday’s close. Year to date, shares of the company have fallen 21.9% compared with the industry’s 21.2% decline. However, the S&P 500 has risen 11.1% in the same timeframe.
The launch of CareIntellect expands GE HealthCare’s portfolio of AI-enabled SaaS applications for health systems and could support further adoption of its digital healthcare solutions. The ability to forecast operational constraints and recommend actions across capacity and throughput may help health systems improve resource utilization and address bottlenecks proactively, creating additional opportunities for GEHC in healthcare technology.
GEHC currently has a market capitalization of $29.02 billion.
Image Source: Zacks Investment Research
More on CareIntellect for Operations
CareIntellect for Operations analyzes hundreds of patient- and operational-level data points, including bed availability, patient delays, staffing, wait times and ancillary services. It provides unit-, department- and enterprise-level views of emerging constraints and is designed to help operational leaders address areas such as discharge, imaging, transfers and capacity.
The application uses two proprietary GEHC AI models. The Pressure Forecast model combines historical hospital operations data with real-time information from electronic medical records (EMRs) and other resource management systems to predict potential constraints across hospitals, departments and units up to 72 hours ahead.
The Estimated Day of Discharge model analyzes longitudinal patient data to estimate when individual patients are likely to be discharged. These estimates are updated hourly as new information becomes available, while recommended actions and prioritized workflows are surfaced to help teams mitigate emerging operational pressure.
The Queen’s Health Systems and Duke Health, serving as the first clinical evaluation sites, will provide frontline feedback to inform future enhancements. CareIntellect for Operations also builds on more than two decades of GE HealthCare’s hospital operations expertise, including its Command Center software, which is used by nearly 500 hospitals and medical facilities globally.
Industry Prospects Favoring the Market
Going by the data provided by Markets and Markets, the global AI in hospital operations market was valued at $7.51 billion in 2025 and is expected to witness a CAGR of 27.9% through 2030.
Factors such as workforce shortages, rising administrative burdens and the growing need to improve hospital operational efficiency while maintaining quality of care are expected to drive market growth. The increasing adoption of AI-based predictive and decision-support solutions could further support demand for technologies aimed at optimizing capacity, patient flow and resource utilization.
Other News
GE HealthCare recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system closer to the U.S. market with the submission to the FDA for 510(k) clearance. Following its recent CE Mark, the milestone marks continued progress toward expanding access to next-generation molecular imaging technologies and supporting a broader range of nuclear medicine applications.
Veracyte reported a second-quarter 2026 adjusted earnings per share (EPS) of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
Globus Medical reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Inspire Medical reported second-quarter 2026 adjusted EPS of 14 cents, which beat the Zacks Consensus Estimate by 163.6%. Revenues of $200.6 million surpassed the Zacks Consensus Estimate by 2.9%.
INSP has an estimated long-term earnings growth rate of 10.6%. INSP’s earnings surpassed estimates in the trailing four quarters, the average surprise being 195.9%.
View the Zacks #1 Rank List
Image: Bigstock
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations
Key Takeaways
GE HealthCare Technologies Inc. (GEHC - Free Report) recently introduced CareIntellect for Operations, an AI-powered Software-as-a-Service (SaaS) application that enables health systems to anticipate capacity challenges up to 72 hours ahead and proactively manage emerging operational bottlenecks. The Queen’s Health Systems and Duke Health will be the first health systems to implement the application.
CareIntellect for Operations is part of GE HealthCare’s CareIntellect family of clinical and operational applications, which use a common cloud-first infrastructure. The application runs on Amazon Web Services (AWS) and is available directly from GE HealthCare and through the AWS Marketplace.
Per GE HealthCare management, CareIntellect for Operations is designed to help health systems identify where operational pressure is building and determine the appropriate next steps. The solution combines patient and operational data with proprietary AI models to provide predictive insights and workflow-connected recommendations, supporting efforts to optimize resources and manage capacity at critical decision points.
GEHC Stock Trend Following the News
Following the announcement, GEHC stock lost 0.3% at yesterday’s close. Year to date, shares of the company have fallen 21.9% compared with the industry’s 21.2% decline. However, the S&P 500 has risen 11.1% in the same timeframe.
The launch of CareIntellect expands GE HealthCare’s portfolio of AI-enabled SaaS applications for health systems and could support further adoption of its digital healthcare solutions. The ability to forecast operational constraints and recommend actions across capacity and throughput may help health systems improve resource utilization and address bottlenecks proactively, creating additional opportunities for GEHC in healthcare technology.
GEHC currently has a market capitalization of $29.02 billion.
Image Source: Zacks Investment Research
More on CareIntellect for Operations
CareIntellect for Operations analyzes hundreds of patient- and operational-level data points, including bed availability, patient delays, staffing, wait times and ancillary services. It provides unit-, department- and enterprise-level views of emerging constraints and is designed to help operational leaders address areas such as discharge, imaging, transfers and capacity.
The application uses two proprietary GEHC AI models. The Pressure Forecast model combines historical hospital operations data with real-time information from electronic medical records (EMRs) and other resource management systems to predict potential constraints across hospitals, departments and units up to 72 hours ahead.
The Estimated Day of Discharge model analyzes longitudinal patient data to estimate when individual patients are likely to be discharged. These estimates are updated hourly as new information becomes available, while recommended actions and prioritized workflows are surfaced to help teams mitigate emerging operational pressure.
The Queen’s Health Systems and Duke Health, serving as the first clinical evaluation sites, will provide frontline feedback to inform future enhancements. CareIntellect for Operations also builds on more than two decades of GE HealthCare’s hospital operations expertise, including its Command Center software, which is used by nearly 500 hospitals and medical facilities globally.
Industry Prospects Favoring the Market
Going by the data provided by Markets and Markets, the global AI in hospital operations market was valued at $7.51 billion in 2025 and is expected to witness a CAGR of 27.9% through 2030.
Factors such as workforce shortages, rising administrative burdens and the growing need to improve hospital operational efficiency while maintaining quality of care are expected to drive market growth. The increasing adoption of AI-based predictive and decision-support solutions could further support demand for technologies aimed at optimizing capacity, patient flow and resource utilization.
Other News
GE HealthCare recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system closer to the U.S. market with the submission to the FDA for 510(k) clearance. Following its recent CE Mark, the milestone marks continued progress toward expanding access to next-generation molecular imaging technologies and supporting a broader range of nuclear medicine applications.
GE HealthCare Technologies Inc. Price
GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote
GEHC’s Zacks Rank & Other Key Picks
Currently, GEHC carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the broader medical space are Veracyte (VCYT - Free Report) , Globus Medical (GMED - Free Report) and Inspire Medical Systems (INSP - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Veracyte reported a second-quarter 2026 adjusted earnings per share (EPS) of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
Globus Medical reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Inspire Medical reported second-quarter 2026 adjusted EPS of 14 cents, which beat the Zacks Consensus Estimate by 163.6%. Revenues of $200.6 million surpassed the Zacks Consensus Estimate by 2.9%.
INSP has an estimated long-term earnings growth rate of 10.6%. INSP’s earnings surpassed estimates in the trailing four quarters, the average surprise being 195.9%.